FluMist Quadrivalent influenza virus vaccine nasal spray applicator, live attenuated 10000000 FFU/strain/0.2 mL dose

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

Influenza virus, Quantity: 10000000 FFU

Available from:

AstraZeneca Pty Ltd

INN (International Name):

Influenza virus

Pharmaceutical form:

Spray, nasal

Composition:

Excipient Ingredients: arginine hydrochloride; monosodium glutamate monohydrate; sucrose; monobasic potassium phosphate; Gelatin; dibasic potassium phosphate; water for injections

Administration route:

Nasal

Units in package:

1, 10

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

FluMist Quadrivalent is indicated for the prevention of influenza in children and adolescents from 24 months to less than 18 years of age.

Product summary:

Visual Identification: Nasal spray - colourless to pale yellow, clear to opalescent suspension. Small white particles may be present; Container Type: Nasal applicator; Container Material: Glass Type I Clear; Container Life Time: 18 Weeks; Container Temperature: Store at 2 to 8 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2016-10-18